Matthew Campbell, MD, MS
Dr Matt Campbell is an associate professor in the Department of Genitourinary Medical Oncology at UT MD Anderson Cancer Center in Houston, TX. He serves as the associate medical director of the Genitourinary Center. He has been recognized for outstanding work in medical education and received the MD Anderson Division of Cancer Medicine Melvin L Samuels award for excellence in Patient Care. He performs clinical and translational research focused on kidney, bladder, adrenal, and testicular cancers. He currently has been rewarded a Department of Defense translational research partnership award focused on kidney cancer bone metastases.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:PfizerTopic:Bladder CancerDate added:10/24/2024Date updated:10/24/2024Relationship end date:10/15/2027
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AstraZenecaTopic:Bladder CancerDate added:10/24/2024Date updated:10/24/2024Relationship end date:10/15/2027
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:ExelixisTopic:Kidney CancerDate added:10/24/2024Date updated:10/24/2024Relationship end date:12/15/2027
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:JanssenTopic:Kidney CancerDate added:10/24/2024Date updated:10/24/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:EisaiTopic:Kidney Cancer Advisory BoardDate added:10/24/2024Date updated:10/24/2024Relationship end date:10/24/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:PfizerTopic:Bladder Cancer Advisory BoardDate added:10/24/2024Date updated:10/24/2024Relationship end date:06/12/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:SeaGenTopic:Bladder Cancer Advisory BoardDate added:10/24/2024Date updated:10/24/2024Relationship end date:10/24/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:ExelixisTopic:Kidney Cancer Advisory BoardDate added:10/24/2024Date updated:10/24/2024Relationship end date:10/24/2025
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Curio SciencesTopic:Kidney Cancer and Bladder Cancer Education forumsDate added:10/24/2024Date updated:10/24/2024Relationship end date:10/04/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Dava OncologyTopic:Kidney Cancer Education ForumDate added:10/24/2024Date updated:10/24/2024Relationship end date:10/01/2024